ATRIDOX Drug Patent Profile
Which patents cover Atridox, and when can generic versions of Atridox launch?
Atridox is a drug marketed by Den-mat and is included in one NDA.
The generic ingredient in ATRIDOX is doxycycline hyclate. There is one drug master file entry for this compound. Seventy-seven suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Atridox
A generic version of ATRIDOX was approved as doxycycline hyclate by STRIDES PHARMA on March 29th, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ATRIDOX?
- What are the global sales for ATRIDOX?
- What is Average Wholesale Price for ATRIDOX?
Summary for ATRIDOX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 52 |
| Clinical Trials: | 2 |
| Patent Applications: | 2,651 |
| What excipients (inactive ingredients) are in ATRIDOX? | ATRIDOX excipients list |
| DailyMed Link: | ATRIDOX at DailyMed |
Recent Clinical Trials for ATRIDOX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Forsyth Institute | Phase 2 |
| National Institute of Dental and Craniofacial Research (NIDCR) | Phase 2 |
| Milton S. Hershey Medical Center | N/A |
US Patents and Regulatory Information for ATRIDOX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Den-mat | ATRIDOX | doxycycline hyclate | SYSTEM, EXTENDED RELEASE;PERIODONTAL | 050751-001 | Sep 3, 1998 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
